3-10355304-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001001331.4(ATP2B2):​c.2136+3387A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.372 in 151,954 control chromosomes in the GnomAD database, including 11,172 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 11172 hom., cov: 31)

Consequence

ATP2B2
NM_001001331.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0590

Publications

6 publications found
Variant links:
Genes affected
ATP2B2 (HGNC:815): (ATPase plasma membrane Ca2+ transporting 2) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 2. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ATP2B2 Gene-Disease associations (from GenCC):
  • hearing loss, autosomal dominant 82
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal recessive nonsyndromic hearing loss 12
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.552 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP2B2NM_001001331.4 linkc.2136+3387A>G intron_variant Intron 14 of 22 ENST00000360273.7 NP_001001331.1 Q01814-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP2B2ENST00000360273.7 linkc.2136+3387A>G intron_variant Intron 14 of 22 5 NM_001001331.4 ENSP00000353414.2 Q01814-1

Frequencies

GnomAD3 genomes
AF:
0.372
AC:
56518
AN:
151836
Hom.:
11171
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.261
Gnomad AMI
AF:
0.500
Gnomad AMR
AF:
0.509
Gnomad ASJ
AF:
0.307
Gnomad EAS
AF:
0.519
Gnomad SAS
AF:
0.572
Gnomad FIN
AF:
0.381
Gnomad MID
AF:
0.437
Gnomad NFE
AF:
0.383
Gnomad OTH
AF:
0.386
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.372
AC:
56557
AN:
151954
Hom.:
11172
Cov.:
31
AF XY:
0.379
AC XY:
28185
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.262
AC:
10834
AN:
41390
American (AMR)
AF:
0.509
AC:
7777
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.307
AC:
1066
AN:
3470
East Asian (EAS)
AF:
0.519
AC:
2680
AN:
5160
South Asian (SAS)
AF:
0.570
AC:
2749
AN:
4822
European-Finnish (FIN)
AF:
0.381
AC:
4021
AN:
10566
Middle Eastern (MID)
AF:
0.456
AC:
134
AN:
294
European-Non Finnish (NFE)
AF:
0.383
AC:
26024
AN:
67944
Other (OTH)
AF:
0.386
AC:
816
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1735
3470
5204
6939
8674
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
548
1096
1644
2192
2740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.389
Hom.:
6088
Bravo
AF:
0.371
Asia WGS
AF:
0.574
AC:
1992
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
3.0
DANN
Benign
0.81
PhyloP100
0.059
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3774180; hg19: chr3-10396988; API